CD8A and cancer: In our first exploratory study, immune senescence was significantly higher in elderly cancer patients than in age-matched controls; in particular, cancer patients, compared to controls, exhibited similar percentages of senescent CD4 lymphocytes, but higher percentages of senescent CD8 cells [7].